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Background: To estimate the prevalence, socio-demographic distribution, treatment and control of diabetes
mellitus in Panama.
Methods: A cross-sectional, descriptive study was conducted in the provinces of Panama and Colon, applying a
survey on cardiovascular risk factors and analyzing biochemical indicators in 3590 persons. A single-stage, probabilistic,
and randomized sampling strategy with a multivariate stratification was used. Individuals with a previous medical
diagnosis of diabetes, glycemia ≥ 126 mg/dl and/or glycosylated hemoglobin ≥ 6.5% (≥ 48 mmol/mol) were considered
with diabetes mellitus. The prevalence estimates were calculated as percentages with 95% confidence intervals and a
p value. Logistic regression was used to identify the sociodemographic variables that were significantly associated with
diabetes. Odds ratio and p values were calculated using 2 x 2 tables, and a value of p≤ 0.05 was considered statistically
significant.
Results: Of the participants, 7.3% (262/3590) were aware of having diabetes and 2.2% (78/3590) were unaware. The
estimated prevalence of diabetes mellitus was 9.5% (340/3590) and increased in proportion to increasing age. The
logistic regression revealed relationships between diabetes and age, sex, area of residence and sociocultural groups.
77.9% of the people aware of having diabetes received treatment and 53.4% have not stabilized the disease.
Conclusions: The research evidenced a high prevalence of diabetes mellitus in Panama, where being Afro-Panamanian
and 50 years of age or older are sociodemographic risk factors for DM. Due to the complications that the disease may
present we recommend actively searching for such cases to increase diagnosis of people unaware of having diabetes.
Keywords: Prevalence of diabetes mellitus in Panama, Sociodemographic distribution of diabetes mellitus, Treatment
and control of diabetes mellitusBackground
Diabetes Mellitus (DM), particularly type 2, which accounts
for 90% - 95% of all cases [1-3], has become a global health
problem [4]. It is estimated that by the year 2030, there will
be 552 million people affected by this disease, an increase
of 50.8% from the 366 million cases recorded in 2011 [5].
It is considered equivalent to coronary heart disease in
its public health impact [6] because it shortens life ex-
pectancy and deteriorates quality of life. Worldwide, it is* Correspondence: ansemc@hotmail.com
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distribution, and reproduction in any mediumalso one of the leading causes of blindness [2,3,7,8],
chronic kidney failure [2,3,8-10], amputations [2,3,8,11]
and other complications [2,3], all of which lead to sig-
nificant disability and increase health care costs.
A patient with DM, given the multiple complications
of the disease, incurs significant health care costs. In
Spain, for example, the cost per patient is 1,305 EUR per
year [12], and in the United States, the hospitalization
costs associated with diabetes total $12 billion dollars
per year [13].
Because DM is usually a silent disease in its initial
stages [14], only a proactive search for it will lead to aentral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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estimated that 26.7% of people with diabetes are un-
aware that they suffer from the disease [15].
For this reason, type 2 DM is often diagnosed rela-
tively late (between 4–7 years after the disease initially
developed) [14]. Therefore, when patients are diagnosed,
many have already developed chronic complications
from the disease. In the United Kingdom’s Prospective
Diabetes Study, of the patients with type 2 DM, 25% had
retinopathy, 9% had neuropathy and 8% had nephropa-
thy at the time of the diagnosis [16].
In most countries, DM is among the top ten causes of
death [17]. In Panama, according to the National Institute
of Statistics and Census (INEC for its acronym in
Spanish), DM was the fifth leading cause of death in
2011, representing 5.5% (836/15240) of the total num-
ber of registered deaths [18].
Increases in population growth, aging of a population
and urban development are social determinants associ-
ated with an increase in the prevalence of DM [19].
Thus, population health surveys are important because
they can determine the potential impact of sociodemo-
graphic variables on the epidemiologic behavior of this
disease.Figure 1 Republic of Panama. Political and administrative divisions.Until 2012, there were no epidemiological indicators
about DM in the Panamanian population. This article
provides new information about this region and aims to
estimate the prevalence, sociodemographic distribution,
treatment and control of diabetes mellitus in Panama.
The analysis in this study used the findings from the
first Survey on Risk Factors Associated with Cardiovas-
cular Disease (PREFREC for its acronym in Spanish),
which was conducted with individuals 18 years and older
between October 2010 and January 2011 by the Gorgas
Memorial Institute for Health Research (GMI) and the
Panamanian Ministry of Health (MOH).Methods
Research design and area
A cross-sectional, descriptive study was conducted in the
trans-isthmian zone of the Republic of Panama. The prov-
inces of Panama and Colon, 5 health regions, and the city
of Panama (capital of the Republic) are located in this re-
gion in which 2,212,722 of the 3,787,511 inhabitants of
the country reside, according to estimates produced by
the INEC [20]. The country is located at the southernmost
end of Central America (Figure 1).
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The universe included individuals aged 18 years and
older who resided in occupied private homes (according
to maps produced by the national census for the year
2000). The INEC employed a single-stage, probabilistic,
and randomized sampling strategy with a multivariate
stratification. The census segments were used as selec-
tion strata; samples were calculated separately for urban,
rural and indigenous land use areas in the study. The
primary sampling units comprised 8–30 private occu-
pied homes, which were first stratified according to the
Administrative Political Code of the Republic and then
by population size. Internally, they were stratified ac-
cording to the education level of the study population.
To produce independent estimates for each of the
study domains, a sample of independent size was chosen
for each domain. We used a level of confidence of 95%
and various error levels (5%, 6.5%, 7% or 10%). The sam-
ple size was calculated assuming a non-response rate of
10%. A total of 3,505 completed interviews were ex-
pected by the end of the survey, which would guarantee
the maximum relative error for the average estimates of
the variables.
Inclusion criteria: Individuals aged 18 and older who
permanently resided in private homes in the appropriate
census segment; willingness to participate in the survey;
and willingness to fast for a period of 8–12 hours.
Exclusion criteria: People with severe physical or men-
tal disabilities that prevented them from directly respond-
ing to the questions in the questionnaire; lack of fluency
in Spanish or a native language; people who resided in pri-
vate homes that were vacant when the researchers visited
the census segment.
Definitions of variables
Area: Geographic domain where the respondent usually
lives (urban, rural or indigenous).
Age: Years from the time of the individual’s birth until
the survey was conducted.
Sex: Phenotypical characteristics that distinguish men
from women.
Schooling: Grade or school year completed by the
interviewee.
Marital status: State of an individual with regard to
marriage or free union with a partner (single; married or
united; separated or divorced; or widowed).
Sociocultural groups: Cultural, social, economic and
ethnic conditions in which an individual lives that influ-
ence his interaction with the environment and deter-
mine his lifestyle. The following classifications were
used: African-American or Afro-Panamanian, Mestizos,
Asian, White, Native American or other.
Monthly family income: Total amount of money (in
USD) received by the family of the respondent on amonthly basis. USD 600 was used as the cutoff because
it is one of the reference points established by INEC
(with this amount of money, a Panamanian family can
have access to a basic food basket).
People with diabetes: An individual who reported
having a medical diagnosis of DM. We also included
the individuals who did not have a medical diagnosis
but who presented blood glucose values ≥ 126 mg/dl
and/or a glycosylated hemoglobin percentage (HbA1c) ≥
6.5% (≥ 48 mmol/mol) [2,21,22].
People aware of having diabetes: Individuals who re-
ported a medical diagnosis of DM.
People with controlled diabetes: People with diabetes
who had values of HbA1c < 7.0% (< 53 mmol/mol) [2,21].
People unaware of having diabetes: Individuals who
had fasting blood glucose ≥ 126 mg/dl or HbA1c ≥ 6.5%
(≥ 48 mmol/mol) but no reported history of a medical
diagnosis.
Data sources, data collection instruments and procedures
Because this is a population-based survey, the data
sources were individuals and biological samples (blood).
The data collection instrument was a structured form
(survey), developed by researchers from GMI whom are
specialists in the department of Chronic Diseases of the
MOH and representatives of the Pan American Health
Organization in Panama. The planning process for the
study included a pilot test to evaluate the methodology,
procedures, instruments and the organization of the field-
work, thus reducing the risk for bias. The instrument was
also validated by nationally recognized specialists in the
fields of endocrinology, cardiology, nephrology, neurology
and public health.
The questionnaire was administered by professionals
and students in their final year of Health Sciences educa-
tion, who were trained by the researchers in interviewing
and survey management to standardize the data collection
process. In the indigenous areas, the survey administrators
were supported by interpreters who spoke the indigenous
dialect.
The fieldwork was conducted on weekends. To guar-
antee an adequate response rate and to ensure that the
participants would be fasting, the population segments
were visited 15 days before the survey was conducted.
Using the spiral scanning technique, we conducted a
random survey of people aged 18 years and older resid-
ing in occupied housing who agreed to participate in the
research (maximum 2 adults per household).
The participants were given a flyer explaining the ob-
jectives of the research, confidentiality, the voluntary na-
ture of the study, where to go on the day of the survey,
and the fasting requirements (i.e., do not consume food
for 8–12 hours or drink alcoholic beverages for 24 hours
prior to blood sample collection).
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fore (Saturday) the administration of the survey (Sunday)
to remind people about the research and to guarantee
fasting and participation. On the day of the survey, the
researchers confirmed that the participants met the
fasting criteria before collecting the blood samples.
To measure serum glucose levels, the blood samples
were collected in gel tubes without anticoagulant, and
tubes containing Ethylenediaminetetraacetic Acid (EDTA)
were used to measure HbA1c. Using high-tech, portable
centrifuges, the samples were centrifuged for 10 minutes
at 3,500 rpm according to the established protocol. The
tubes were placed in containers with frozen packs (2–8°C)
to be transferred to the GMI and analyzed at the Central
Reference Laboratory in Public Health using the Beckman
Synchron CX7 clinical system (multiple wavelength spec-
trophotometer with diffraction reticle and original re-
agents). The samples were processed daily, and calibration
methods and equipment quality control measures were
applied.
Quality control and data capture
Five trained individuals (1 per health region) adminis-
tered 3,590 surveys, thereby reducing the risk of error.
After the data were collected, 3 of the 5 surveyors per-
formed a quality control check by verifying the data in
the 3,590 completed surveys, thus providing a clean
database for the analysis.
Analysis plan
The prevalence estimates from the study sample were
calculated as percentages with 95% confidence intervals
and a p value. Comparisons were made with the age-
adjusted rates for the Panamanian population in 2012
[20]. Logistic regression was used to identify the socio-
demographic variables that were significantly associated
with DM, and a risk analysis was performed [odds ratio
(OR)]. ORs and p values were calculated using 2 × 2 ta-
bles, and a value of p ≤ 0.05 was considered statistically
significant [23,24].
The data were entered in the CS-Pro 4.0 program in
accordance with INEC’s recommendation and processed
using SPSS (version 19), Microsoft Excel 2010, Manifold
8 and the free version of Epi info (version 3.5.1).
All of the participants signed an informed consent
form. The research was approved by the National Bio-
ethics Committee of the Republic of Panama.
Results
General characteristics
The response rate (for both the survey and the fasting
blood sampling) was 102.4% (3590/3505), which included
1074 men (29.9%) and 2516 women (70.1%). Of the re-
spondents, 20.5% (735) were young adults (18–29 years),57.5% (2064) were adults (30–59 years) and 22.0% (791)
were seniors (aged 60 and over). The average age of the
respondents was 45 years (48 for men, 44 for women) and
the median was 44 years (49 for men, 43 for women).
Prevalence and sociodemographic distribution
Of the participants, 7.3% (262/3590) were aware of having
diabetes; 5.7% (204/3590) had fasting glycemic values ≥
126 mg/dl; 4.3% (156/3590) had HbA1c levels ≥ 6.5%
(≥48 mmol/mol); and 2.2% (78/3590) were unaware of
having diabetes. Overall, these figures indicated that the
estimated prevalence of DM was 9.5% (340/3590). The
age-adjusted rate of DM for the 2012 Panamanian popula-
tion was estimated at 7.7% (Table 1).
A lower prevalence of DM was found in indigenous
areas compared with urban and rural areas. With regard
to sex, 10.3% of men (111/1074) and 9.1% of women
(229/2516) had diabetes (Table 1).
In general, the rate of DM increased in proportion to
increasing age. The rate of DM was higher among men
than women under 50 years old, but for older individ-
uals, the prevalence of DM was greater among women
(Figure 2).
With regard to other sociodemographic variables, the
highest prevalence rates were found among Afro-
Panamanians [11.9%; (90/757), p < 0.05], widowers [16.0%
(26/163; p < 0.05)], those earning 600 USD and above per
month [12.2% (62/507; p < 0.05)] and holding post-
graduate degrees (16.1%; 10/62), while the lowest preva-
lence rate was recorded among indigenous groups [5.4%;
(21/391), p < 0.05] (Table 1).
The logistic regression revealed relationships between
DM and age (p < 0.0001), sex (p < 0.0001), area of resi-
dence (p < 0.0001) and sociocultural groups (p = 0.0241).
Being Afro-Panamanian and 50 years or older are socio-
demographic risk factors associated with DM in Panama,
Table 2.
Treatment and control
Of the 340 people with diabetes, 77.1% (262/340) were
aware of having diabetes and 22.9% (78/340) were un-
aware. In addition, 60.0% (204/340) were receiving treat-
ment and 40.0% (136/340) were not. Only 53.4% (109/204)




This is the first epidemiological study conducted in
Panama on the prevalence of cardiovascular risk factors,
including DM. A strict methodology was employed to
reduce bias and to ensure that the data were statistically
representative, high quality, precise and accurate.
Among the studies that were consulted, PREFREC was
Table 1 Specific and age adjusted rates of people with diabetes mellitus according to the sociodemographic variables
of the research











Frequency % Frequency % Frequency %
Total 3590 100.0 340 9.5 8.5–10.5 NA 7.7 3250 90.5
Area
Urban 1688 47.0 177 10.5 9.0–12.0 0.0575 7.9b 1511 89.5
Rural 1699 47.3 156 9.2 7.8–10.6 0.6148 8.0b 1543 90.8
Indigenous 203 5.7 7 3.4 0.9–5.9 0.0038 3.3b 196 96.6
Sex
Men 1074 29.9 111 10.3 8.5–12.1 0.2742 8.2 963 89.7
Women 2516 70.1 229 9.1 8.0–10.2 7.9 2287 90.9
Age (years)
18-29 735 20.5 11 1.5 0.0–2.4 0.0000 1.5 724 98.5
30-39 692 19.3 35 5.1 3.5–6.7 0.0000 5.1 657 94.9
40-49 715 19.9 58 8.1 6.1–10.1 0.1884 8.1 657 91.9
50-59 657 18.3 101 15.4 12.6–18.2 0.0000 15.4 556 84.6
60 and over 791 22.0 135 17.1 14.7–19.7 0.0000 17.1 656 82.9
Sociocultural groups
African American (Afro-Panamanian) 757 21.1 90 11.9 9.6–14.2 0.0090 9.5 667 88.1
Mestizo 1937 54.0 168 8.7 7.4–10.0 0.1319 7.0 1769 91.3
Asian 27 0.8 2 7.4 0–16.0 NA 5.8 25 92.6
Native 391 10.9 21 5.4 3.2–7.6 0.0053 5.0 370 94.6
White 431 12.0 51 11.8 8.8–14.8 0.0745 9.3 380 88.2
Others 44 1.2 8 18.2 NA NA 18.0 36 81.8
Not specified (No response) 3 0.1 0 0.0 NA NA NA 3 100.0
Monthly family income
600 USD and more 507 14.1 62 12.2 9.4–15.0 0.0342 9.7 445 87.8
Less than 600 USD 2929 81.6 267 9.1 8.1–10.1 7.6 2662 90.9
Does not know/Does not work 154 4.3 11 7.1 NA NA 4.1 143 92.9
Marital status
Single 734 20.4 66 9.0 6.9–11.1 0.6543 8.6 668 91.0
Free union or married 2460 68.5 229 9.3 8.2–10.4 0.6229 7.8 2231 90.7
Separated or divorced 225 6.3 19 8.4 4.8–12.0 0.6627 5.0 206 91.6
Widow 163 4.5 26 16.0 10.4–21.6 0.0061 5.9 137 84.0
Not specified (No response) 8 0.2 0 0.0 NA NA NA 8 100.0
Schooling
No schooling 186 5.2 10 5.4 2.2–8.6 0.0673 2.3 176 94.6
Elementary 1188 33.1 129 10.9 9.1–12.7 0.0528 7.2 1059 89.1
High school 1499 41.8 125 8.3 6.9–9.7 0.0570 8.0 1374 91.7
University 622 17.3 59 9.5 7.2–11.8 0.9510 9.3 563 90.5
Post-graduate 62 1.7 10 16.1 7.0–25.2 0.1124 15.1 52 83.9
Not specified (No response) 33 0.9 7 21.2 7.3–35.1 NA NA 26 78.8
aP value was carried out among the total number of people with diabetes and without diabetes (according area, sex, age groups, sociocultural groups, monthly
family income, marital status and schooling).
bAge adjusted rate to Panamanian population for 2010 for urban, rural and indigenous areas.
NA: Not applicable.
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18 - 29 yrs 30 - 39 yrs 40 - 49 yrs 50 - 59 yrs 60 yrs and over
TOTAL 1.5 5.1 8.1 15.4 17.1
MALE 3.3 4.1 12.8 13.9 14.0
FEMALE 0.9 5.4 6.4 16.0 19.1





















Source: Prepared by the authors. PREFREC, 2010-2011.
Figure 2 Prevalence of diabetes mellitus (age and sex adjusted rates).
Table 2 Sociodemographic risk factors (O.R.) associated
with DM in Panama
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nosis of DM (glycemic levels ≥ 126 mg/dl and/or glyco-
sylated hemoglobin ≥ 6.5% (≥ 48 mmol/mol)).
Although the total response rate was 102.4%, the ratio
of female–male responses was 2.3:1, with an even higher
ratio for those under 40 years of age. This result reflects
selection bias, which may be related to the type of sam-
pling strategy used (stratified according to education
level); the cultural traditions in the country and the
greater acceptance of women participating in population-
based research; or the requirement to abstain from alcohol
for 24 hours before the survey, which may have lowered
the participation rate among men.
Using age-adjusted rates allowed us to control for con-
fusion bias. For all of the sociodemographic variables,
the age-adjusted rates were lower than the unadjusted
rates. The effect was most notable for marital status and
schooling. There were no differences between the un-
adjusted rates and the age- or sex- adjusted rates.40-49 0.81 0.60– 1.10
50-59 2.05 1.58–2.65b








Not specified (No response) NA
aO.R. was carried out among the total number of people with diabetes and
without diabetes in urban, rural and indigenous areas; men and women; age
group and sociocultural groups.
bp value < 0.0001.
NA: Not applicable.Prevalence and sociodemographic aspects
The prevalence of DM found by PREFREC (9.5%; CI 8.5 -
10.5) is comparable with other studies [3-5,8,25-29] and
allows us to estimate that in Panama in 2012, there were
238,367 persons with DM. Of these, 144,690 resided in
the trans-isthmian area of the country, where 60.4% of
Panamanians 18 years and older reside [20].
The percentage of people aware of having diabetes was
higher than the value estimated in 2007 by the National
Survey on Health and Quality of Life (5.8%) in the same
area [30]. The high prevalence estimated by PREFREC
justifies allocating government resources to comprehen-
sive care for persons with DM because of the high cost




















Controlled: HbA1c < 7% (< 53mmol/mol)a
b






















Source: Prepared by the authors. PREFREC, 2010-2011.
Figure 3 Treatment and HbA1c levels in people aware of having DM and unaware.
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of their condition. This level of unawareness is com-
parable to other countries in the region [15,29] but
lower than the global estimate of 50% reported by the
International Diabetes Federation [5].
The logistic regression analysis identified the sociode-
mographic variables that were significantly associated
with DM in the Panamanian population.
There was an epidemiological trend toward higher rates
of DM with increasing age. Although the bivariate analysis
(OR) determined that being younger than 40 years old is a
protective factor against DM, the presence of DM in indi-
viduals between 18 and 29 years old suggests that risk fac-
tors (such as obesity, physical inactivity and unhealthy
diets rich in fats and sugars) are present from the earliest
stages of life. Thus, we must consider multiple causes in
the epidemiological profile of DM.
On the other hand, the OR indicates that age is a risk
factor for DM for individuals over age 50. Considering
that Panama’s population pyramid tends to be inverted
and the life expectancy for Panamanians has increased
to 78 years [20], the increase in the number of individ-
uals with DM is expected to continue in the coming
years, as well as the number of deaths caused by this
disease.According to the analysis of risk (OR), being native and
living in the indigenous area are protective factors against
DM. This result suggests that there are certain social, cul-
tural and environmental determinants of DM related to
indigenous lifestyles (e.g., less sedentary lifestyle and less
Westernized eating habits) and justifies the need for con-
ducting other investigations in this population.
The prevalence of DM among Afro-Panamanians is
high, and furthermore, the OR indicates that being Afro-
Panamanian is a risk factor for DM in Panama. In
addition to the genetic component, the influence of diet-
ary habits in this group could be a decisive factor in this
observed high prevalence: high consumption of fatty
meals is deeply rooted in the Afro-Caribbean culture
and contributes to the development of the disease [31].
Although the result was not statistically significant,
there were more men with DM than women [29]. How-
ever, among those older than 60, the prevalence was
higher among women, which coincides with the projec-
tions made by other authors, who suggest that this sex/
age pattern may occur because senior populations have a
greater number of women than men [19]. On the other
hand, the higher prevalence of DM among older women
may increase the probability of death among women com-
pared with men, which would explain the increase in the
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served in the country over the last 5 years (1.3:1) [18].
The fact that there is a higher prevalence in the sub-
group of widows could be related to the relatively older
age of widowed persons in addition to the possible effect
of loneliness as a source of emotional tension and a
cause of neglect in self-care.
The prevalence of DM was directly proportional to
monthly family income. The increase in prevalence
among individuals with higher incomes could be ex-
plained by their greater purchasing power, which could
increase caloric intake and reduce physical activity. Indi-
viduals in this group may own automobiles for transpor-
tation and may have more educational opportunities
that enable them to find jobs requiring less physical
activity.
The differences in education seem to follow the trend
in income. Individuals with higher education have higher
incomes, which would explain the higher prevalence.
Therefore, although it might seem that a higher educa-
tional level would be a protective factor because an edu-
cated person would have greater knowledge about the
impact of lifestyle factors on health and more accurate risk
perception [32], the consequences of a higher income
(mentioned previously) exceed the benefits afforded by a
higher educational level.
Treatment and control
Interestingly, 53.4% (109/204) of those who were
aware of having diabetes had an HbA1c value < 7.0%
(< 53 mmol/mol), which indicates appropriate meta-
bolic control [21,26,33,34]. This figure compares fa-
vorably with the results from other nations [28,35].
However, 46.6% (95/204) of DM patients have not sta-
bilized the disease, and undoubtedly, we must strive to
reduce this figure.
It is worth noting that among the individuals who
were aware of having diabetes, only 77.9% were receiving
treatment (medication). Although the cause was not in-
vestigated, we can report that 2 out of every 10 persons
with a medical diagnosis of DM do not comply with the
current international guidelines for receiving treatment
from the time of diagnosis [21,33].
Additionally, 22.1% (58/262) of the people who were
aware of having diabetes were not taking medication for
their disease. Of these, 87.9% (51/58) had an HbA1c
value < 7.0%, and 46.1% (36/78) of the people unaware of
having diabetes also had values in this range. These re-
sults suggest that although these people had altered glu-
cose metabolism at the moment of the survey, there had
not been sufficient time for sustained hyperglycemia to
generate glycosylation greater than 7%. Another possibil-
ity is that these individuals had less aggressive diabetes
(given the slight elevation in their glycemic levels), sothey had not experienced symptoms that prompted them
to seek medical attention and receive a diagnosis. In
addition, other risk and protective factors related to life-
style (type of food, physical activity, etc.) and demograph-
ics should also be considered as explanatory variables.
These statistics should be evaluated by health profes-
sionals because if these individuals are not diagnosed
and do not receive timely medical treatment, their
HbA1c values will eventually exceed 7%, producing
macro- and micro-vascular complications. Over the mid-
dle and long term, these health problems will increase
the economic and social burden of the disease in the
country.
Conclusions
This study found that the prevalence of DM was 9.5%.
Because this research included a representative sample
of urban, rural and indigenous populations, and because
there have been no previous studies on this topic, these
results can be used as a country public health indicator.
Being Afro-Panamanian and 50 years of age or older
are sociodemographic risk factors for DM in Panama,
whereas being native, 39 years of age or younger and
living in an indigenous area are protective factors.
The Panamanian health system must make an effort to
reach the 22.9% of people who are unaware that they
have DM and are thus not receiving treatment. This
effort would reduce health complications and improve
the quality of life for individuals with the disease, so we
recommend actively searching for such cases.
This information is essential for developing integrated
care programs targeting people with DM.
Abbreviations
DM: Diabetes Mellitus; INEC for its acronym in Spanish: National Institute of
Statistics and Census; PREFREC for its acronym in Spanish: Survey on Risk
Factors Associated to Cardiovascular Disease; GMI: Gorgas Memorial Institute
for Health Research; MOH: Panamanian Ministry of Health;
EDTA: Ethylenediaminetetraacetic Acid; HbA1c: Glycosylated hemoglobin;
USD: United States Dollars; O.R.: Odds Ratio.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
AMcD researched, analysis and interpretation of data, wrote the manuscript and
gave final approval of the version to be published. JM wrote the manuscript
and gave final approval of the version to be published. CC analysis and
interpretation of data. AR have been involved in drafting the manuscript and
revising it critically for important intellectual content. AC researched data and
has been involved in drafting the manuscript. All authors read and approved
the final manuscript.
Acknowledgements
We thank the researchers and the technical and administrative personnel
who participated in developing PREFREC 2010–2011. This manuscript was
funded by the budget of GMI.
Author details
1Gorgas Memorial Institute for Health Research, Justo Arosemena Avenue
and 35th Street, Panama, Republic of Panama. 2Ministry of Health, Santo
Mc Donald P et al. Diabetology & Metabolic Syndrome 2013, 5:69 Page 9 of 9
http://www.dmsjournal.com/content/5/1/69Tomas Hospital. Endocrinology Service, Balboa Avenue and 34th East Street,
Panama, Republic of Panama. 3School of Statistics, Faculty of Sciences.
University of Panama, Transisthmian Avenue, Panama, Republic of Panama.
Received: 22 March 2013 Accepted: 9 November 2013
Published: 13 November 2013References
1. Engelgau M, Geiss L, Saaddine J, et al: The evolving diabetes burden in
the United States. Ann Intern Med 2004, 140:945–950.
2. American Diabetes Association: Diagnosis and Classification of Diabetes
Mellitus. Diabetes Care 2010, 33:S62–S69.
3. Deshpande A, Harris-Hayes M, Schootman M: Epidemiology of Diabetes
and Diabetes-Related Complications. Phys Ther 2008, 88:1254–1264.
4. Olaiz-Fernández G, Rojas R, Aguilar-Salinas C, Rauda J, Villalpando S:
Diabetes mellitus en adultos mexicanos. Resultados de la Encuesta
Nacional de Salud 2000. Salud Publica Mex 2007, 49:S331–S337.
5. International Diabetes Federation: Diabetes Atlas. 5th Edition update. 2012.
http://www.idf.org/media-events/press-releases/2011/diabetes-atlas-5th-
edition.
6. Third Report of the National Cholesterol Education Program (NCEP): Expert
Panel on Detection, Evaluation, and Treatment of High Blood
Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation
2002, 106:3143–3421.
7. Lloyd A: Perspectives on diabetic retinopathy. Am J Ophthalmol 2003,
136:122–135.
8. Barceló A, Rajpathak S: Incidence and prevalence of diabetes mellitus in
the Americas. Rev Panam Salud Publica 2001, 10:300–308.
9. Ritz E, Reinhold S: Nephropathy in patients with type 2 diabetes mellitus.
N Engl J Med 1999, 341:1127–1133.
10. Krolewski M, Eggers P, Warram J: Magnitude of end-stage renal disease in
IDDM: a 35 year follow-up study. Kidney Int 1996, 50:2041–2046.
11. Selvin E, Erlinger T: Prevalence of and risk factors for peripheral arterial
disease in the United States: results from the National Health and
Nutrition Examination Survey, 1999–2000. Circulation 2004,
110(6):738–743.
12. Ministerio de Sanidad y Consumo: Centro de publicaciones. España:
Estrategia en diabetes del Sistema Nacional de Salud; 2007.
13. American Diabetes Association: Economics Consecuenses of
Diabetes Mellitus in US in 1997. American Diabetes Association 1998,
1:14.
14. Harris M, Klein R, Welborn T, Knuiman M: Onset of NIDDM occurs at
least 4–7 yr before clinical diagnosis. Diabetes Care 1992, 15:815–819.
15. Roger V, Go A, Lloyd-Jones D, et al: Heart Disease and Stroke Statistics —
2011 Update: A Report From the American Heart Association. Circulation
2011, 123:e18–e209.
16. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose
control with sulphonylureas or insulin compared with conventional
treatment and risk of complications in patients with type 2 diabetes
(UKPDS 33). Lancet 1998, 352:837–853.
17. World Health Organization: The top 10 causes of death. http://who.int/
mediacentre/factsheets/fs310/en/.
18. Contraloría General de la República, Instituto Nacional de Estadística y
Censo: Estadísticas vitales. Defunciones en la República, por sexo, según edad y
principales causas de muerte. Panamá: Año; 2007–2011.
19. Wild S, Roglic G, Green A, Sicree R, King H: Global Prevalence of Diabetes.
Diabetes Care 2004, 27:1047–1053.
20. Contraloría General de la República, Instituto Nacional de Estadística y
Censo: Estadísticas vitales: Estimaciones y Proyecciones de la Población Total,
Provincia y Comarca Indígena según Sexo y Edad: al 1 de julio de 2000–2030.
Panamá. Cuadro 11. [http://www.contraloria.gob.pa/inec/Publicaciones/
Publicaciones.aspx?ID_SUBCATEGORIA=10&ID_PUBLICACION=491&ID_
IDIOMA=1&ID_CATEGORIA=3].
21. American Diabetes Association: Standards of Medical Care in Diabetes —
2012. Diabetes Care 2012, 35:S4–S10.
22. Goldenberg R, Cheng A, Punthakee Z, Clement M: Use of Glycated
Hemoglobin (A1C) in the Diagnosis of Type 2 Diabetes Mellitus in
Adults. Canadian Journal of Diabetes 2011, 35:247–249.
23. Clark M: Los valores P y los intervalos de confianza: ¿en qué confiar?
Rev Panam Salud Publica 2004, 15:293–296.24. Newcombe R, Merino C: Intervalos de confianza para las estimaciones de
proporciones y las diferencias entre ellas. Interdisciplinaria 2006,
23:141–154.
25. Asociación Latinoamericana de Diabetes: Epidemiología de la Diabetes
Mellitus en Latinoamérica. Revista de la Asociación Latinoamericana de
Diabetes 2000, 1:116–119.
26. Rosado J, Martínez M, Mantilla T, et al: Prevalencia de diabetes en una
población adulta de Madrid (España). Gac Sanit 2012, 26:243–250.
27. Satman I, Yilmaz T, Seng¨ul A, et al: Population-Based Study of Diabetes
and Risk Characteristics in Turkey. Diabetes Care 2002, 25:1551–1555.
28. Villalpando S, De la Cruz V, Rojas R, et al: Prevalence and distribution of
type 2 diabetes mellitus in Mexican adult population. A probabilistic
survey. Salud Publica Mex 2010, 52:S19–S26.
29. Barcelo A, Gregg E, Gerzoff R, et al: Prevalence of Diabetes and
Intermediate Hyperglycemia Among Adults From the First Multinational
Study of Noncommunicable Disease in Six Central American Countries.
The Central America Diabetes Iniciative (CAMDI). Diabetes Care 2012,
35:738–740.
30. Gómez B, González B, Luque H, Mc Donald A, Moreno DeRivera A, Roa R:
Encuesta Nacional de Salud y Calidad de Vida. Panamá: Instituto
Conmemorativo Gorgas de Estudios de la Salud; 2009.
31. Van Dam R, Willett W, Rimm E, Stampfer M, Hu F: Dietary fat and meat
intake in relation to risk of type 2 diabetes in men. Diabetes Care 2002,
25:417–424.
32. Castillo-Arriaga A, Delgado-Sánchez V, Carmona-Suazo J: Percepción de
riesgo familiar a desarrollar diabetes mellitus. Rev Med Inst Mex Seguro Soc
2006, 44:505–510.
33. Insuchi S, Bergenstal R, Buse J, et al: Management of Hyperglycemia in
Type 2 Diabetes: A Patient-Centered Approach. Diabetes Care 2012,
35:1364–1379.
34. Simó R, Hernández C: Tratamiento de la diabetes mellitus: objetivos
generales y manejo en la práctica clínica. Rev Esp Cardio 2002,
55:845–860.
35. Saydah S, Fradkin J, Cowie C: Poor Control of Risk Factors for Vascular
Disease Among Adults With Previously Diagnosed Diabetes. JAMA 2004,
291:335–342.
doi:10.1186/1758-5996-5-69
Cite this article as: Mc Donald P et al.: Prevalence, sociodemographic
distribution, treatment and control of diabetes mellitus in Panama.
Diabetology & Metabolic Syndrome 2013 5:69.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
